Armata Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Los Angeles, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Armata Pharmaceuticals, Inc. has filed 1,147 SEC EDGAR filings since 06 Feb 1996

SEC filing history

Showing 201-225 of 694 matching filings.

Per page
25
Current page
9
4

OWNERSHIP DOCUMENT

Filing date
09 Jun 2021
Reporting date
07 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
09 Jun 2021
Reporting date
07 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
09 Jun 2021
Reporting date
07 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-256104

EFFECT filing

Filing date
20 May 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-256104

424B3

Filing date
20 May 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
18 May 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
18 May 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37544

FORM 8-K

Filing date
14 May 2021
Reporting date
13 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-256104

FORM S-3

Filing date
13 May 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-37544

DEFA14A

Filing date
22 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-37544

DEF 14A

Filing date
21 Apr 2021
Reporting date
07 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
05 Apr 2021
Reporting date
01 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
05 Apr 2021
Reporting date
01 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37544

FORM 8-K

Filing date
05 Apr 2021
Reporting date
01 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-44887

SCHEDULE 13D (AMENDMENT NO. 4)

Filing date
05 Apr 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
26 Mar 2021
Reporting date
25 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
26 Mar 2021
Reporting date
25 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
26 Mar 2021
Reporting date
25 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
26 Mar 2021
Reporting date
25 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-44887

SCHEDULE 13D/A, AMENDMENT #3

Filing date
17 Mar 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Mar 2021
Reporting date
17 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37544

FORM 8-K

Filing date
17 Mar 2021
Reporting date
16 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-37544

DEF 14A

Filing date
26 Feb 2021
Reporting date
16 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .